Back to Search
NEDA RASOULI, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1336247295IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
47940(CO)
Education
OTHER
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans.
PMID 19667111·Arterioscler Thromb Vasc Biol·2009
2-rct
Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action.
PMID 19336660·Am J Physiol Endocrinol Metab·2009
8-other
Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects.
PMID 18728164·J Clin Endocrinol Metab·2008
7-preclinical
Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness.
PMID 18697866·J Clin Endocrinol Metab·2008
7-preclinical
Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.
PMID 18057090·Diabetes·2008
8-other
Intermuscular lipid: a marker of disordered fat partitioning or the consequence of obesity?
PMID 18541542·Am J Clin Nutr·2008
8-other
Calcium is involved in formation of high molecular weight adiponectin.
PMID 18510435·Metab Syndr Relat Disord·2008
8-other
Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines.
PMID 18544642·Am J Physiol Endocrinol Metab·2008
2-rct
Adipocytokines and the metabolic complications of obesity.
PMID 18987272·J Clin Endocrinol Metab·2008
6-review
Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
PMID 17090638·J Clin Endocrinol Metab·2007
8-other
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.
PMID 18200815·Vasc Health Risk Manag·2007
6-review
Impact of family history of diabetes and ethnicity on -cell function in obese, glucose-tolerant individuals.
PMID 17878257·J Clin Endocrinol Metab·2007
8-other
Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.
PMID 17595259·J Clin Endocrinol Metab·2007
8-other
Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent.
PMID 17579832·Diabetologia·2007
8-other
Effects of pioglitazone and metformin on beta-cell function in nondiabetic subjects at high risk for type 2 diabetes.
PMID 16968813·Am J Physiol Endocrinol Metab·2007
2-rct
OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.
PMID 17130488·Diabetes·2006
7-preclinical
The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment.
PMID 16894240·J Lipid Res·2006
7-preclinical
Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes.
PMID 16803857·Am J Physiol Endocrinol Metab·2006
7-preclinical
Pioglitazone induces apoptosis of macrophages in human adipose tissue.
PMID 16799131·J Lipid Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1336247295
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile